These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 18250556)

  • 21. Severity Indices for Obstructive Sleep Apnea Syndrome Reflecting Glycemic Control or Insulin Resistance.
    Isobe Y; Nakatsumi Y; Sugiyama Y; Hamaoka T; Murai H; Takamura M; Kaneko S; Takata S; Takamura T
    Intern Med; 2019 Nov; 58(22):3227-3234. PubMed ID: 31327833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of nCPAP therapy on cardiorespiratory outcomes in obstructive sleep apnea syndrome: compliance and technological advancements.
    Toraldo DM; De Nuccio F; Nicolardi G
    Expert Rev Respir Med; 2011 Feb; 5(1):41-7. PubMed ID: 21348585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of obstructive sleep apnea and nasal CPAP on circulating adiponectin levels.
    Yoshikawa M; Yamauchi M; Fujita Y; Koyama N; Fukuoka A; Tamaki S; Yamamoto Y; Tomoda K; Kimura H
    Lung; 2014 Apr; 192(2):289-95. PubMed ID: 24395128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of continuous positive airway pressure therapy on inflammatory cytokines and atherosclerosis in patients with obstructive sleep apnea syndrome.
    Jin F; Liu J; Zhang X; Cai W; Zhang Y; Zhang W; Yang J; Lu G; Zhang X
    Mol Med Rep; 2017 Nov; 16(5):6334-6339. PubMed ID: 28901415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating adrenomedullin in obstructive sleep apnoea.
    Schulz R; Flötotto C; Jahn A; Eisele HJ; Weissmann N; Seeger W; Rose F
    J Sleep Res; 2006 Mar; 15(1):89-95. PubMed ID: 16490007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome.
    Noda A; Nakata S; Koike Y; Miyata S; Kitaichi K; Nishizawa T; Nagata K; Yasuma F; Murohara T; Yokota M
    Hypertens Res; 2007 Aug; 30(8):669-76. PubMed ID: 17917313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome.
    Ursavaş A; Karadağ M; Rodoplu E; Yilmaztepe A; Oral HB; Gözü RO
    Respiration; 2007; 74(5):525-32. PubMed ID: 17148932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of nasal resistance on initial acceptance of continuous positive airway pressure in treatment for obstructive sleep apnea syndrome.
    Sugiura T; Noda A; Nakata S; Yasuda Y; Soga T; Miyata S; Nakai S; Koike Y
    Respiration; 2007; 74(1):56-60. PubMed ID: 16299414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma adrenomedullin and obstructive sleep apnea.
    Wolk R; Svatikova A; Otto ME; Hoffmann MS; Duenwald CJ; Somers VK
    Am J Hypertens; 2004 Jan; 17(1):74-6. PubMed ID: 14700517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of treatment with nasal continuous positive airway pressure on ventilatory response to hypoxia and hypercapnia in patients with sleep apnea syndrome.
    Spicuzza L; Bernardi L; Balsamo R; Ciancio N; Polosa R; Di Maria G
    Chest; 2006 Sep; 130(3):774-9. PubMed ID: 16963674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated plasma levels of soluble (pro)renin receptor in patients with obstructive sleep apnea syndrome: association with polysomnographic parameters.
    Nishijima T; Tajima K; Takahashi K; Sakurai S
    Peptides; 2014 Jun; 56():14-21. PubMed ID: 24657284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obstructive sleep apnea syndrome: coagulation anomalies and treatment with continuous positive airway pressure.
    Toraldo DM; De Benedetto M; Scoditti E; De Nuccio F
    Sleep Breath; 2016 May; 20(2):457-65. PubMed ID: 26169715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure.
    Takahashi K; Chin K; Nakamura H; Morita S; Sumi K; Oga T; Matsumoto H; Niimi A; Fukuhara S; Yodoi J; Mishima M
    Antioxid Redox Signal; 2008 Apr; 10(4):715-26. PubMed ID: 18199002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients.
    Dyugovskaya L; Lavie P; Lavie L
    Am J Respir Crit Care Med; 2002 Apr; 165(7):934-9. PubMed ID: 11934717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of nasal continuous positive airway pressure short-term treatment on C-reactive protein and intercellular adhesion molecule-1 in patients with obstructive sleep apnea-hypopnea syndrome].
    Wang YN; Yang Y; Luo YQ; Chen LL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):666-9. PubMed ID: 16708805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of CPAP-therapy on bronchial and nasal inflammation in patients affected by obstructive sleep apnea syndrome.
    Lacedonia D; Salerno FG; Carpagnano GE; Sabato R; Depalo A; Foschino-Barbaro MP
    Rhinology; 2011 Jun; 49(2):232-7. PubMed ID: 21743883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of continuous positive airway pressure on soluble CD40 ligand in patients with obstructive sleep apnea syndrome.
    Kobayashi K; Nishimura Y; Shimada T; Yoshimura S; Funada Y; Satouchi M; Yokoyama M
    Chest; 2006 Mar; 129(3):632-7. PubMed ID: 16537861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome.
    Ohga E; Nagase T; Tomita T; Teramoto S; Matsuse T; Katayama H; Ouchi Y
    J Appl Physiol (1985); 1999 Jul; 87(1):10-4. PubMed ID: 10409552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertension and obstructive sleep apnoea syndrome: current perspectives.
    Baguet JP; Barone-Rochette G; Pépin JL
    J Hum Hypertens; 2009 Jul; 23(7):431-43. PubMed ID: 19129854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of nasal CPAP on exhaled SIRT1 and tumor necrosis factor-α in patients with obstructive sleep apnea.
    Lin CC; Liaw SF; Chiu CH; Chen WJ; Lin MW; Chang FT
    Respir Physiol Neurobiol; 2016 Jul; 228():39-46. PubMed ID: 26976689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.